Clinical trial
A Phase 2, Randomized, Double- Dummy, Observer-Blind Study to Evaluate the Safety and Immunogenicity of Co-administered Novel Live Attenuated Monovalent Oral Poliomyelitis Vaccines in Healthy Young Infants Relative to Monovalent Vaccines Alone in Panama.
NCT06895486 is registered in ClinicalTrials.gov with PATH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Double- Dummy, Observer-Blind Study to Evaluate the Safety and Immunogenicity of Co-administered Novel Live Attenuated Monovalent Oral Poliomyelitis Vaccines in Healthy Young Infants Relative to Monovalent Vaccines Alone in Panama.
- Lead sponsor
- PATH
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- November 11, 2025
- Completion date
- December 28, 2026
- Enrollment
- 675 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.